Sites / Clinical Research Philadelphia
Is this you?

Request access for Clinical Research Philadelphia with your @phillyresearch.com work email. Intera will contact you to verify and set up your account — nothing auto-publishes.

Request account

Clinical Research Philadelphia

Unclaimed profile

Independent Network · Philadelphia, PA · ~2 sites

Intera lens
ICP 6Lift (cardio sample) 0.18Recruit soph 0.57
Quality Scorecard (1–100)
Overall68Recruit52Ops79Sponsor71Ther71

Performance (observed)

Historical trials
182
Completed
106
Terminated/Withdrawn
20
Completion rate
84%
Active now
53
Phase 2
59
Phase 3
93
Realized enrollment
139,757
First study year
1996
Years active
30
Match confidence
high
Enrollment velocity (inf)
4,659

Therapeutic

Areas
Dermatology, Rheumatology, Women's Health, Metabolic Disease, Cardiovascular, Chronic Kidney Disease, Rare Diseases, Migraine, Alzheimer's Disease
Specialties
Liver Disease, Lp(a), Atopic Dermatitis, Cardiovascular, Metabolic
Breadth (conditions)
260
Languages
English + Spanish (detected)
States
PA, NJ

Recruitment (web observed)

Trial Finder
Yes
Patient database
Yes (10,000+ participants since 1996; 500+ completed trials)
Recruitment pages
Yes
Advertises recruitment
Yes
SEO
Y - Active blog, ranks for study terms
Capability notes
AI-based EMR mining for patient recruitment; network of 70+ provider partnerships with access to 300,000+ patients; rapid diversity-focused enrollment; <7 days greenlight to first screen

Relationships

Sponsors
National Institute of Allergy and Infectious Diseases (NIAID); Children's Oncology Group; Gilead Sciences; National Cancer Institute (NCI); Boehringer Ingelheim; Novartis Pharmaceuticals
CROs
IQVIA Pty Ltd; MacroGenics; PRA Health Sciences; Rho Federal Systems Division, Inc.; The Emmes Company, LLC; Worldwide Clinical Trials
Owner / parent
Private; established 1996
Expansion
2 Philadelphia-area locations

Capacity & people

Investigators
Coordinators
CEO
Unknown
VP Clinical Ops
Unknown
VP Site Ops
Unknown
VP Recruitment
Unknown
Emails
Unknown

Tech & DCT

CTMS
Yes - Fully electronic CTMS
EHR
Yes
eSource
Yes
eConsent
Yes
Uses AI
Yes
Builds tech
Vendors
DCT / decentralized
Y - Remote monitoring and decentralized trial support
Tech stack
Fully electronic CTMS (CRIO eSource/eReg); AI-enabled EMR integration; electronic data capture systems
Recruiting visible
Y

Notes

Long-standing site (founded 1996, 500+ trials, 10,000+ participants). 2-site network with strong execution metrics (95% enrollment goal achievement, <7 day activation). AI-driven recruitment using EMR integration; broad provider network (70+ partners, 300K patient access). Diverse enrollment focus aligns with FDA guidance. Limited geographic scope (PA/NJ only). No explicit DCT or multi-state expansion. Tech-enabled recruitment is strong differentiator. [Validated: 25 active recruiting cardiometabolic trials on ClinicalTrials.gov.]

Recommendation features (sample indication)

Ind fit 0.42Liftability 0.18Overall68

FUTURE MOAT: absolute enrollment rates, funnel CPR, measured SSU, screen-fail reasons.